Abstract
NAD(P)H and FAD fluorescence lifetime imaging is used to monitor cancer metabolism. Imaging of 3D primary gastroenteropancreatic neuroendocrine organoids reveals patient specific metabolic differences in response to treatment.
© 2017 Optical Society of America
PDF Article | Presentation VideoMore Like This
Peter Favreau, Cheri Pasch, Dustin Deming, and Melissa Skala
OmS2D.4 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2017
Alex Walsh, Rebecca S. Cook, H. Charles Manning, Donna J. Hicks, Alec Lafontant, Carlos L. Arteaga, and Melissa C. Skala
MT3C.5 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013
Alex J. Walsh, Isabel Jones, Tiffany M. Heaster, Melissa C. Skala, Katie Mueller, and Krishanu Saha
MF2A.4 Microscopy Histopathology and Analytics (Microscopy) 2018